KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cardinal Health (CAH) EBITDA (2016 - 2025)

Cardinal Health (CAH) has disclosed EBITDA for 17 consecutive years, with $707.0 million as the latest value for Q4 2025.

  • Quarterly EBITDA rose 28.78% to $707.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 billion through Dec 2025, up 34.23% year-over-year, with the annual reading at $2.3 billion for FY2025, 83.02% up from the prior year.
  • EBITDA hit $707.0 million in Q4 2025 for Cardinal Health, up from $668.0 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $730.0 million in Q1 2025 to a low of -$950.0 million in Q4 2021.
  • Historically, EBITDA has averaged $284.6 million across 5 years, with a median of $408.0 million in 2021.
  • Biggest five-year swings in EBITDA: crashed 306.07% in 2021 and later skyrocketed 1875.0% in 2024.
  • Year by year, EBITDA stood at -$950.0 million in 2021, then skyrocketed by 90.95% to -$86.0 million in 2022, then skyrocketed by 687.21% to $505.0 million in 2023, then increased by 8.71% to $549.0 million in 2024, then rose by 28.78% to $707.0 million in 2025.
  • Business Quant data shows EBITDA for CAH at $707.0 million in Q4 2025, $668.0 million in Q3 2025, and $428.0 million in Q2 2025.